A quick peek into the report
Table of Contents
1.1 Inclusion and Exclusion Criteria
2.1 Key Questions Answered in the Report:
3.1 Cell-Based Assay Market: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
3.5 Criteria for Company Profiling
4.1 Market Introduction
4.1.1 Types of Cell-Based Assays
4.2 Current and Future State of Cell-Based Assays in Industries
4.3 Emerging Technologies and Applications in the Cell-Based Assay Market
4.4 Current Market Size and Growth Potential, $Billion, 2022-2032
4.5 COVID-19 Impact on Cell-Based Assay Market
4.5.1 Impact on Cell-Based Assay Companies
5.1 Overview
5.2 Legal Requirements and Frameworks in Europe
6.1 Overview
6.2 Impact Analysis
6.2.1 Market Drivers
6.2.1.1 Increase in Demand for Cell-Based Assay in Drug Discovery and Development
6.2.1.2 Rise in Life Sciences Research Investments
6.2.1.3 Technological Advancements
6.2.2 Market Restraints
6.2.2.1 High Cost
6.2.2.2 Lack of Standardization
s
6.2.3 Market Opportunities
6.2.3.1 Increased Focus on Regenerative Medicine
6.2.3.2 Emergence of Novel Gene Editing Technologies
7.1 Competitive Landscape Overview
7.1.1 Key Developments
7.1.2 Product Launch and Expansion Activities
7.1.3 Merger and Acquisition Activities
7.1.4 Synergistic Activities
7.1.5 License and Agreement Activities
7.2 Market Share Analysis (2022)
7.3 Growth-Share Analysis (2021-2022)
7.3.1 Growth-Share Analysis (by Company)
8.1 Overview
8.2 Europe
8.2.1 Germany
8.2.2 U.K.
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest-of-Europe
9.1 Overview
9.1.1 Merck KGaA
9.1.1.1 Company Overview
9.1.1.2 Role of Merck KGaA in the Cell-Based Assay Market
9.1.1.3 Major Product: Key Specifications
9.1.1.4 Key Competitors
9.1.1.5 Analyst Perspective
9.1.2 Lonza Group AG
9.1.2.1 Company Overview
9.1.2.2 Role of Lonza Group AG in the Cell-Based Assay Market
9.1.2.3 Major Product: Key Specifications
9.1.2.4 Key Competitors
9.1.2.5 Analyst Perspective
9.1.3 Sample Company
9.1.3.1 Overview
9.1.3.2 Top Products / Product Portfolio
9.1.3.3 Top Competitors
9.1.3.4 Target Customers
9.1.3.5 Key Personnel
9.1.3.6 Analyst View
9.1.3.7 Market Share
9.1.4 Sample Company
9.1.4.1 Overview
9.1.4.2 Top Products / Product Portfolio
9.1.4.3 Top Competitors
9.1.4.4 Target Customers
9.1.4.5 Key Personnel
9.1.4.6 Analyst View
9.1.4.7 Market Share
9.1.5 Sample Company
any
9.1.5.1 Overview
any
9.1.5.2 Top Products / Product Portfolio
any
9.1.5.3 Top Competitors
any
9.1.5.4 Target Customers
any
9.1.5.5 Key Personnel
any
9.1.5.6 Analyst View
any
9.1.5.7 Market Share
any
9.1.6 Sample Company
any
9.1.6.1 Overview
9.1.6.2 Top Products / Product Portfolio
9.1.6.3 Top Competitors
9.1.6.4 Target Customers
9.1.6.5 Key Personnel
9.1.6.6 Analyst View
9.1.6.7 Market Share
Table 1: Current and Future State of Cell-Based Assay in Industries
Table 2: Utilizing the Potential of Cell-Based Assays: Novel Instruments and Methodologies in 2020-2021
Figure 1: Impact Analysis of Drivers, Challenges, and Opportunities on the Cell-Based Assay Market
Figure 2: Cell-Based Assay Market (by Region), 2022
Figure 3: Cell-based Assay Market Methodology
Figure 4: Primary Research Methodology
Figure 5: Top-Down Approach (Segment-Wise Analysis)
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Cellular Processes Utilized to Investigate the Impacts in Cell-Based Assays
Figure 8: Emerging Technologies in the Cell-Based Assay Market
Figure 9: Cell-Based Assay Market, $Billion, 2022-2032
Figure 10: Impact of COVID-19 on Cell-Based Assay Companies
Figure 11: Cell-Based Assay Market - Market Dynamics
Figure 12: Total U.S. Life Sciences Venture Capital Funding, $Billion, 2016-2021
Figure 13: Uses of Cell-based Assays in Regenerative Medicine
Figure 14: Share of Key Developments and Strategies, January 2020 to March 2023
Figure 15: Share of Product Launch and Expansion Activities (by Company), January 2020 to March 2023
Figure 16: Share of Merger and Acquisition Activities (by Company), January 2020 to March 2023
Figure 17: Share of Synergistic Activities (by Company), January 2020 to March 2023
Figure 18: Market Share Analysis for Cell-Based Assay Market, 2022
Figure 19: Growth-Share Analysis for Cell-Based Assay Market (by Company), 2021-2022
Figure 20: Cell-Based Assay Market Snapshot (by Region)
Figure 21: Cell-Based Assay Market (by Region), $Billion, 2022-2032
Figure 22: Europe Cell-Based Assay Market, $Billion, 2022-2032
Figure 23: Europe: Market Dynamics
Figure 24: Europe Cell-Based Assay Market (by Country), $Billion, 2022-2032
Figure 25: Germany Cell-Based Assay Market, $Billion, 2022-2032
Figure 26: U.K. Cell-Based Assay Market, $Billion, 2022-2032
Figure 27: France Cell-Based Assay Market, $Billion, 2022-2032
Figure 28: Italy Cell-Based Assay Market, $Billion, 2022-2032
Figure 29: Spain Cell-Based Assay Market, $Billion, 2022-2032
Figure 30: Rest-of-Europe Cell-Based Assay Market, $Billion, 2022-2032
Figure 31: Total Number of Companies Profiled
Figure 32: Merck KGaA: Product Portfolio
Figure 33: Lonza Group AG: Product Portfolio
Europe Cell Based Assay Market Report Coverage
|
Europe Cell Based Assay Market Report |
|||
|
Base Year |
2022 |
Market Size in 2022 |
XX |
|
Forecast Period |
2022-2032 |
Value Projection and Estimation by 2032 |
XX |
|
CAGR During Forecast Period |
XX |
|
|
Key Market Players and Competition Synopsis
The featured companies have been meticulously chosen, drawing insights from primary experts and thorough evaluations of company coverage, product offerings, and market presence.
Some prominent names established in this market are:
Merck
Lonza Group AG
Europe Call Based Assay Market Overview
Introduction to Europe Cell-Based Assay Market
The Europe Cell-Based Assay Market is expected to grow at a CAGR of XXXX from XXXX in 2023 to XXXX by 2032 in the forecasted period of 2023-2032. The Cell-Based Assay Market is surging, driven by the pharmaceutical industry's escalating drug discovery efforts and the inherent advantages of these assays over traditional methods. Their ability to mimic human physiology, predict drug efficacy and toxicity early, and personalize medicine fuels demand. This trend is further amplified by rising chronic disease prevalence and supportive government initiatives, fostering a market poised for significant expansion.
Market Introduction
The European cell-based assay market is experiencing a surge, fueled by a confluence of factors. The burgeoning pharmaceutical and biotechnology sectors, with their focus on efficient drug discovery and personalized medicine, are driving demand for these powerful tools. Cell-based assays offer a more human-relevant and cost-effective alternative to traditional animal models, allowing for rapid screening of drug candidates and a deeper understanding of their mechanisms of action. This shift is further bolstered by rising investments in academic research and government initiatives promoting life sciences innovation. However, challenges such as high instrumentation costs and stringent regulatory frameworks necessitate strategic partnerships and technological advancements to unlock the full potential of this rapidly evolving market.
Market Segmentation
Segmentation 1: by Product
• Consumables
• Instruments and Software
• Services
Segmentation 2: by Region
• Europe
Segmentation 3: by Application
• Drug Screening
• Basic Research
• Predictive Toxicology
• Other Applications (Other Industries, Cell and Gene therapy, among others)
Segmentation 4: by Technology
• Flow Cytometry
• Automated Handling
• High Throughput Screening
• High Content Screening
• Other Technologies (Label-Free Detection, Image Cytometry, among others)
Segmentation 5: by End User
• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Other End Users (Government Organizations)
Segmentation 6: by Company
How can this report add value to an organization?
Workflow/Innovation Strategy: The Europe cell-based assay market is segmented (by product) into three categories, i.e., consumables, instruments and software, and services. The consumables segment is further classified as reagents, assay kits, microplates, cell lines, probes and labels, and other consumables.
Growth/Marketing Strategy: The Europe cell-based assay market is anticipated to witness growth during the forecast year 2023-2032. The advent of CRISPR/Cas9 technology has completely transformed gene studies and their functions by offering highly precise and user-friendly genome editing capabilities. CRISPR significantly streamlines the development of more intricate disease-related cell-based assays, enabling researchers to tackle complex questions and study heterogeneous diseases with more relevant and sophisticated assays.
Competitive Strategy: Key players in the Europe cell-based assay market have been analyzed and profiled in the study, including manufacturers involved in new product development, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe cell-based assay market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
How can this report add value to the organization ?
Workflow/Innovation Strategy: The Europe cell-based assay market is segmented (by product) into three categories, i.e., consumables, instruments and software, and services. The consumables segment is further classified as reagents, assay kits, microplates, cell lines, probes and labels, and other consumables.
Growth/Marketing Strategy: The Europe cell-based assay market is anticipated to witness growth during the forecast year 2023-2032. The advent of CRISPR/Cas9 technology has completely transformed gene studies and their functions by offering highly precise and user-friendly genome editing capabilities. CRISPR significantly streamlines the development of more intricate disease-related cell-based assays, enabling researchers to tackle complex questions and study heterogeneous diseases with more relevant and sophisticated assays.
Competitive Strategy: Key players in the Europe cell-based assay market have been analyzed and profiled in the study, including manufacturers involved in new product development, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe cell-based assay market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Europe Cell-Based Assay Market
Analysis and Forecast, 2023-2032
Frequently Asked Questions
The Europe cell-based assay market is expected to reach $11.12 billion by 2032 from $5.17 billion in 2023, at a CAGR of 8.88% during the forecast period 2023-2032.
A cell-based assay is a laboratory method employing cultured living cells to examine and assess diverse biochemical or cellular processes. This approach enables researchers to observe cellular responses under specific experimental conditions, offering insights into parameters like cell motility, toxicity, proliferation, and morphology. Cell-based assays find significant applications in drug discovery, diagnostics, and the production of measurable products. Frequently, researchers use gene assays alongside cell-based assays to enhance sensitivity and amplify signals in cell-signaling cascades, making these assays suitable for miniaturization.
The Cell-Based Assay Market is witnessing a rise in complexity, not just at the level of individual cells but also within entire culture systems. Researchers are increasingly integrating multiple cell types to establish co-cultures and explore mutual dependencies, often replicating physiological 3D environments. Moreover, there's a notable integration of cell-based assays into dynamic systems within bioreactors and their miniaturization using microfluidic chips.
Different types of assays in cell culture include viability assays to assess cell health, proliferation assays to measure cell growth, apoptosis assays for programmed cell death detection, and migration assays to study cell movement. These assays offer valuable insights into various cellular processes, aiding research in fields like drug discovery and disease study.